Aims Recent guidelines recommend four core drug classes (renin–angiotensin system
inhibitor/angiotensin receptor–neprilysin inhibitor [RASi/ARNi], beta-blocker …

Background Polypharmacy is common among patients with heart failure with reduced
ejection fraction (HFrEF). However, its impact on the use of optimal guideline-directed …

Background Patterns and disparities in guideline-directed medical therapy (GDMT) uptake
for heart failure with reduced ejection fraction (HFrEF) across rural vs urban regions are not …

Abstract Purpose of Review The polypill strategy, originally developed to improve
medication adherence, has demonstrated efficacy in improving baseline systolic blood …

Background Older adults with heart failure often experience adverse drug events with high
doses of heart failure medications. Recognizing whether a patient is on a high or low dose …

Background Significant gap remains in the implementation of guideline‐directed medical
therapy (GDMT) in patients with heart failure after a hospitalization. We aimed to evaluate …

BACKGROUND: A polypill containing all 4 classes of guideline-directed medical therapy for
heart failure with reduced ejection fraction (HFrEF) has been proposed to change the heart …

Heart failure (HF) is emerging as a major public health problem both in high-and low-income
countries. The mortality and morbidity due to HF is substantially higher in low-middle income …

The Nigerian Cardiovascular Symposium is an annual conference held in partnership with
cardiologists in Nigeria and the diaspora to provide updates in cardiovascular medicine and …

Heart failure (HF) is a significant global health concern, particularly in Asia, where over half
of the world's population resides. Despite advances in treatment, the burden of HF is …